Krka, d.d., a prominent pharmaceutical company headquartered in Slovenia (SI), has established itself as a leader in the global healthcare industry since its founding in 1946. With a strong presence in Europe and beyond, Krka focuses on the development, production, and marketing of prescription pharmaceuticals, over-the-counter products, and animal health medications. Renowned for its commitment to quality and innovation, Krka offers a diverse range of products, including generic medicines and proprietary brands, which are distinguished by their efficacy and affordability. The company has achieved significant milestones, including numerous awards for its research and development efforts, solidifying its position in the competitive pharmaceutical landscape. With a robust market presence and a dedication to sustainability, Krka continues to contribute to the advancement of healthcare worldwide.
How does Krka's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Krka's score of 42 is higher than 61% of the industry. This can give you a sense of how well the company is doing compared to its peers.
In 2024, Krka, headquartered in Slovenia (SI), reported total carbon emissions of approximately 598,682,000 kg CO2e. This figure includes 56,868,000 kg CO2e from Scope 1 emissions, which are direct emissions from owned or controlled sources, and 17,133,000 kg CO2e from Scope 2 emissions, which are indirect emissions from the generation of purchased electricity, heat, and steam. Notably, Scope 3 emissions accounted for a significant portion, totalling about 524,681,000 kg CO2e, primarily driven by purchased goods and services (422,552,000 kg CO2e). In comparison, emissions for 2023 were approximately 74,018,000 kg CO2e for Scope 1 and 2 combined, with Scope 1 emissions at 59,029,000 kg CO2e and Scope 2 emissions at 14,989,000 kg CO2e. The data indicates a slight increase in total emissions from 2023 to 2024, reflecting the complexities of managing emissions across various scopes. Krka has not publicly committed to specific reduction targets or initiatives, as there are no documented SBTi (Science Based Targets initiative) reduction targets or climate pledges. The absence of such commitments suggests a need for further development in their climate strategy. The company’s emissions data is self-reported and does not cascade from any parent organization, indicating that Krka, d. d. is independently managing its emissions reporting and climate commitments.
Access structured emissions data, company-specific emission factors, and source documents
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|
| Scope 1 | 66,245,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 2 | - | - | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 3 | - | - | - | - | - | 000,000,000 |
The vast majority of their carbon footprint comes from suppliers and value chain emissions, representing the vast majority of total emissions under the GHG Protocol, with "Purchased Goods and Services" being the largest emissions source at 81% of Scope 3 emissions.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Krka has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.

